Trade Mark Clearance: A Cautionary Tale For Brand Expansion
Brand owners seeking to expand their product offerings should conduct thorough trade mark searches to ensure their marks are clear for use in new categories.
Lawyers Still Debating the Law on Novelty – What’s New about That?
In the recent decision of Dyno Nobel v Orica Explosives, Justice Downs needed to decide the correct date at which the disclosure of a novelty citation is assessed-the date of publication of the citation or the priority date of the patent in issue.
A Close Call for Medicinal Chemists!
Fresh off the press from the UK Court of Appeal is a decision concerning the pharmaceutical drug Xtandi (Enzalutamide). Xtandi is indicated in various oncology treatments in Australia and is listed at number 19 the of top 200 selling pharmaceuticals by retail in 2024.
PROTACs and Protein Degraders: Claiming Space in a Crowded IP Field
The emergence of protein degraders, including proteolysis-targeting chimeras (PROTACs) and molecular glues, represents one of the most exciting shifts in drug discovery over the past 20 years.
COVID Symptoms Linger for Trade Mark Non-Use Applications
Trade mark owners and non-use removal applicants have been offered a reminder of the importance of considering any obstacles to the use of a trade mark by the decision in Thomas v Monsoon Group.
IPO Introduces Assisted AI Patent Search Reports
We are pleased to announce IPO is now offering Assisted AI Patent Searches. The reports provide a researcher assisted AI Patent search which is modified and focused by using keyword and/or IPC/CPCs.
Australia: Sector-Specific Trends and Legal Challenges Highlight Importance of Forward-Looking IP Strategy
Australia’s life sciences ecosystem is experiencing sustained growth, driven by advances in biotechnology, digital health, precision medicine, agricultural innovation and materials science.
Trustee’s ‘Inherited Financial Circumstances’ Insufficient to Justify Extension of Time Request
In the recent decision of Aqua HD [2025] APO 2, the Delegate denied a request for an extension of time made by a patent applicant’s trustee, who had been appointed by the court to wind down the company following insolvency proceedings.
Tempted to use AI for your IP Advice?
You might be tempted to ask Artificial Intelligence for legal advice. But as we’ve seen from the decision in Valu v Minister for Immigration it’s not a reliable source of information.
USPTO Significantly Increases Fees From January 2025
The United States Patent and Trademark Office (USPTO) has announced significant fee changes for US IP rights, effective from 18 January 2025.